Orchestra BioMed Holdings OBIO Cash Flow Statement (2020-2026)

NASDAQ OBIO
$6.01 +0.28 (+4.89%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Orchestra BioMed Holdings Quarterly Cash Flow Statement

Periods 25 quarters
Latest Sep 2026

Orchestra BioMed Holdings reported cash from operations of -$19.54M and free cash flow of -$19.94M for the quarter ended Sep 2026, down 34.3% year over year. This cash flow statement covers 25 quarters of results from Sep 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-0.09M-5.73M-0.73M-0.69M-9.75M-10.94M-12.05M-13.32M-12.82M-13.46M-15.98M-15.43M-16.16M-18.76M-19.36M-20.83M6.25M-20.69M-23.76M-18.75M
Depreciation and DepletionDep. & Depletion
0.05M0.05M0.05M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.08M0.08M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.06M0.04M0.04M0.04M0.04M0.04M0.04M0.00M0.05M0.05M0.06M0.06M0.06M0.07M0.07M
Depreciation & Amortization (CF)Dep. & Amort.
0.05M0.05M0.05M0.07M0.07M0.07M0.07M0.07M0.07M0.07M0.08M0.08M0.08M0.08M0.08M0.08M0.09M0.10M0.10M
Share-based CompensationStock Comp.
0.07M0.22M2.22M0.86M1.49M1.71M3.51M0.92M2.59M2.76M2.36M2.90M2.97M3.25M3.01M2.75M2.85M2.51M2.29M
Gains from Investment SecuritiesGains Investment
0.00M-0.22M1.73M-0.31M-0.17M0.01M-0.03M0.29M-0.29M-0.05M-0.02M2.24M0.32M6.14M
Other non-cash itemsOther Non-Cash
0.28M1.70M-0.04M0.38M0.45M0.16M0.16M1.36M0.07M0.17M0.28M1.19M0.15M0.15M0.15M0.16M0.16M0.17M0.17M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.04M0.00M0.02M-0.02M0.10M-0.09M0.01M-0.03M0.01M0.04M-0.04M0.00M-0.01M-0.03M0.04M-0.01M-0.03M0.01M
Change in InventoryChange Inventory
-0.04M0.10M0.20M-0.05M-0.04M-0.05M-0.04M0.01M-0.03M-0.05M0.16M-0.06M-0.04M0.05M0.18M-0.06M-0.03M-0.03M-0.03M
Change in Account PayablesChange Payables
-267.000.10M0.07M0.11M0.10M
Change in Accrued ExpensesChange Accrued Exp.
0.03M0.20M0.03M1.62M1.06M-1.80M0.78M0.67M0.49M-1.28M3.73M1.23M-0.71M-0.20M1.09M3.41M0.57M-3.06M-0.25M0.85M
Change in Other Operating AssetsOther Assets Change
-0.03M-0.07M0.56M-0.01M-0.04M1.50M-0.77M-0.27M0.32M0.06M-0.11M0.59M0.53M-0.04M-0.11M-0.14M-0.59M0.48M-0.49M0.05M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.62M-0.38M-1.13M-1.05M-1.19M-0.90M-0.45M-0.27M-0.56M-0.80M-1.08M-0.22M-0.86M-0.80M-0.86M-13.45M-0.17M-0.19M-0.19M
Other Working Capital ChangesOther WC Changes
0.03M-0.55M-0.93M-1.12M-1.02M-2.69M-0.13M-0.18M-0.59M-0.62M-0.69M-1.67M-0.75M-0.83M-0.69M-0.72M-12.86M-0.65M0.30M-0.24M
Cash from OperationsCash from Ops.
-0.03M-5.32M-7.97M-7.26M-8.74M-14.38M-10.49M-10.28M-10.97M-13.11M-10.21M-13.70M-13.54M-16.62M-15.53M-14.55M-2.27M-22.17M-19.33M-19.54M
Investing Activities
Capital ExpendituresCapex
0.05M0.27M0.22M0.05M0.04M0.03M0.02M0.00M0.01M0.11M0.07M0.11M0.11M0.03M0.31M0.03M0.18M0.25M0.40M
Change in Property, Plant and EquipmentChange in PP&E
-0.05M-0.27M-0.22M-0.05M-0.04M-0.03M-0.02M0.00M-0.01M-0.11M-0.07M-0.11M-0.11M-0.03M-0.31M-0.03M-0.18M-0.25M-0.40M
Acquisitions
4.50M
Net of Acquisitions & DivestmentsNet Acquisitions
-4.50M
Purchase of InvestmentsInvestments Purchased
63.32M43.49M56.06M38.52M3.96M23.74M18.65M9.99M20.27M2.90M47.78M25.63M13.13M43.00M6.49M
Sale and Maturity of InvestmentsInvestments Sold
51.49M37.11M29.61M29.18M10.61M17.23M16.01M16.39M9.51M7.95M23.63M19.95M27.86M
Other Investing Activities (as filed)Other investing (as filed)
Cash from Investing ActivitiesCash from Investing
-0.05M-0.47M-0.22M-63.38M-43.53M8.12M12.95M33.15M5.86M10.42M0.56M-3.75M13.00M16.36M-38.58M-17.71M10.32M-23.31M20.97M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
-0.04M5.86M14.15M
Long-Term Debt RepaymentsLT Debt Repayment
1.00M5.45M
Net Long-Term Debt Issued (Repaid)Net LT Debt
-1.00M-5.45M-0.04M5.86M14.15M
Net Short-Term Debt Issued (Repaid)Net ST Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
-1.00M-5.45M-0.04M5.86M14.15M
Change in Capital Stock
Common Stock IssuedStock Issued
0.10M0.10M0.00M0.01M0.09M0.00M0.15M0.02M0.17M15.04M0.05M0.09M57.78M1.54M5.88M0.01M6.02M
Shares Repurchased
1.50M-94.09M
Net Shares Issued and RepurchasedNet Shares Issued
-1.40M0.10M94.10M0.01M0.09M0.00M0.15M0.02M0.17M15.04M0.05M0.09M57.78M1.54M5.88M0.01M6.02M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
27.28M82.55M
Net Equity Issued and RepurchasedNet Equity Issued
25.88M82.65M94.10M0.01M0.09M0.00M0.15M0.02M0.17M15.04M0.05M0.09M57.78M1.54M5.88M0.01M6.02M
Other financing activities (as filed)
-1.61M-1.12M-2.50M5.23M56.81M-0.39M-0.43M-0.27M-0.47M-0.35M-0.26M-0.16M
Cash from Financing ActivitiesCash from Financing
24.76M86.08M-2.50M-5.09M56.82M0.09M0.00M-10.70M0.02M0.17M15.04M13.95M-0.30M-0.43M76.40M12.66M5.53M34.75M5.86M
Additional items
Change in Cash
-0.03M19.39M77.64M-9.98M-77.21M-1.09M-2.29M2.67M11.48M-7.24M0.39M1.89M-3.34M-3.91M0.40M23.26M-7.32M-6.32M-7.90M7.29M
Ending Cash Balance
9.94M29.33M106.97M97.00M19.78M18.70M16.41M19.08M30.56M23.32M23.71M25.61M22.26M18.35M18.75M42.01M34.69M28.37M20.47M27.76M
Free Cash FlowFCF
-0.03M-5.37M-8.23M-7.48M-8.80M-14.42M-10.52M-10.30M-10.97M-13.12M-10.31M-13.77M-13.64M-16.73M-15.56M-14.86M-2.30M-22.35M-19.59M-19.94M
Net Cash FlowNCF
-0.03M19.39M77.64M-9.98M-77.21M-1.09M-2.29M2.67M11.48M-7.24M0.39M1.89M-3.34M-3.91M0.40M23.26M-7.32M-6.32M-7.90M7.29M
Interest Paid
0.09M0.65M0.30M0.33M0.35M0.37M0.38M0.02M0.36M0.36M0.36M0.36M0.36M0.36M0.37M

Orchestra BioMed Holdings Cash Flow Statement API

Pull Orchestra BioMed Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=OBIO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY